PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $38,000 | +11.8% | 11,947 | +2.1% | 0.01% | 0.0% |
| Q2 2020 | $34,000 | +3.0% | 11,701 | 0.0% | 0.01% | -15.4% |
| Q1 2020 | $33,000 | -17.5% | 11,701 | -5.5% | 0.01% | 0.0% |
| Q4 2019 | $40,000 | -7.0% | 12,382 | -17.8% | 0.01% | -13.3% |
| Q3 2019 | $43,000 | -4.4% | 15,071 | +4.4% | 0.02% | -31.8% |
| Q2 2019 | $45,000 | -15.1% | 14,439 | +0.8% | 0.02% | -15.4% |
| Q1 2019 | $53,000 | – | 14,330 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |